Who
Jason Pitofsky
SVP Controller
Company insider
Files Form 4 as: SVP Controller, Regeneron Pharmaceuticals.
In numbers
- Trades disclosed
- 39
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $4.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Apr 2024
- Last trade
- 9 Feb 2026
- Last filed
- 11 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $492K1,000 at $492.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $113K144 at $783.23 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $7851 at $784.66 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $42K53 at $785.72 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $16K20 at $775.95 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $405K521 at $776.43 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $304K391 at $777.51 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $438K563 at $778.35 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $160K205 at $779.56 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $59K75 at $780.06 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $20K26 at $781.37 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $492K1,000 at $492.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $16K20 at $775.95 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $405K521 at $776.43 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $304K391 at $777.51 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $438K563 at $778.35 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $160K205 at $779.56 | filing |
| 9 Feb 2026filed 11 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $59K75 at $780.06 | filing |
News
1,598 Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Perpetual LtdREGN · dailypolitical.com · 15 Oct 2026Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Up 3.6% – Here's What HappenedREGN · dailypolitical.com · 14 Oct 2026Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $780.00REGN · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Jason Pitofsky; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.